Fireside Chat: Unlocking the Next Frontier of Cell Therapy

This session explores the expanding frontiers of cell therapy, moving beyond oncology into autoimmune and other complex diseases, while addressing critical CMC challenges and growing investment interest in in vivo approaches. Moderated by John Tomtishen, Global Head of Cell Therapy Field Application Scientists and Strategic Alliances at Catalent, the discussion draws on his deep expertise in cell and gene therapy development, manufacturing, and commercialization. Attendees will gain forward-looking perspectives on scalable manufacturing solutions, regulatory considerations, and strategic innovation required to broaden patient access and deliver transformative impact across multiple therapeutic areas.